REYL & Cie S.A.’s iShares US Medical Devices ETF IHI Stock Holding History

REYL & Cie S.A.’s Portfolio IHI Stock Details IHI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$340K	Buy	+6,365	New	+$323K	0.39%	49

Other funds holding IHI

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

AAS

Annex Advisory Services Brookfield, Wisconsin $5.86B AUM 21.83% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

REYL & Cie S.A.'s IHI Position: Q2 2026 in Review

REYL & Cie S.A. opened a new position in iShares US Medical Devices ETF (IHI) in Q2 2026: 6,365 shares worth $340K. The stake represents 0.39% of the portfolio and ranks #49 among its holdings.

505 funds tracked by Wall St. Rank hold IHI as of Q2 2026.

REYL & Cie S.A. held 6,365 shares of iShares US Medical Devices ETF worth $340K as of Q2 2026.
iShares US Medical Devices ETF was a new REYL & Cie S.A. position in Q2 2026.
iShares US Medical Devices ETF made up 0.39% of REYL & Cie S.A.'s portfolio in Q2 2026, its #49 holding.
505 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q2 2026.

Based on REYL & Cie S.A.'s 13F filing for Q2 2026, filed 2 Oct 2026.